| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/24/2005 | US20050261189 Methods of promoting cardiac cell proliferation |
| 11/24/2005 | US20050261187 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy |
| 11/24/2005 | US20050261186 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/24/2005 | US20050261185 Therapeutic proteins |
| 11/24/2005 | US20050261184 Method for treating glaucoma |
| 11/24/2005 | US20050261183 PTHrP-derived modulators of smooth muscle proliferation |
| 11/24/2005 | US20050261182 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 11/24/2005 | US20050261181 Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells |
| 11/24/2005 | US20050261180 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 11/24/2005 | US20050261179 Vasoregulating compounds and methods of their use |
| 11/24/2005 | US20050261178 Administering to patient therapeutic dose of cytokine in combination with antibodies directed against tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN); method characterized in significantly reduced cytokine-related toxicity combined with potentiated effectiveness of anti-G250 antibody alone |
| 11/24/2005 | US20050261177 Compound |
| 11/24/2005 | US20050261176 Compositions and methods relating to novel compounds and targets thereof |
| 11/24/2005 | US20050261175 monoclonal antibody immunoreactive with a stem cell factor; hybridoma cell line; can stimulate growth of primitive progenitors including early hematopoietic progenitor cells |
| 11/24/2005 | US20050261174 Insecticidal activity of a cyclic peptide |
| 11/24/2005 | US20050261173 Antifungal parenteral products |
| 11/24/2005 | US20050261172 Peptide for increasing bone density; peptide is glycosylated, is 4 amino acids in length; the amino acid sequence consists of a sequence identical to the first 4 consecutive amino acids |
| 11/24/2005 | US20050261169 Peptide and peptide mimetic derivatives having integrin inhibitor properties III |
| 11/24/2005 | US20050261168 Novel formulations |
| 11/24/2005 | US20050261167 Compositions for sleeping disorders |
| 11/24/2005 | US20050261166 Compositions and methods for the therapy and diagnosis of lung cancer |
| 11/24/2005 | US20050261163 Pharmaceutical products, preparation and uses thereof |
| 11/24/2005 | US20050260767 Treatment with cytokines |
| 11/24/2005 | US20050260754 Constructs and methods for the regulation of gene expression |
| 11/24/2005 | US20050260753 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 11/24/2005 | US20050260734 Packaging cells |
| 11/24/2005 | US20050260733 Proteases and uses thereof |
| 11/24/2005 | US20050260731 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 11/24/2005 | US20050260717 Double transdominant fusion gene and protein |
| 11/24/2005 | US20050260713 Polypeptides and nucleic acids encoding same |
| 11/24/2005 | US20050260709 Lipin1 function |
| 11/24/2005 | US20050260708 Proteases and protease inhibitors |
| 11/24/2005 | US20050260702 Novel integrin alpha subunit and uses thereof |
| 11/24/2005 | US20050260693 Tumor suppressor gene |
| 11/24/2005 | US20050260682 Compositions and methods for diagnosing or treating psoriasis |
| 11/24/2005 | US20050260674 Specific polypeptides, useful as nematocides |
| 11/24/2005 | US20050260673 nematode-specific gene products that can serve as targets for inhibitory peptides and proteins (e.g., antibodies) and antiparasitic chemicals |
| 11/24/2005 | US20050260670 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 11/24/2005 | US20050260644 Cell signaling proteins |
| 11/24/2005 | US20050260634 Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor |
| 11/24/2005 | US20050260629 Differential drug sensitivity |
| 11/24/2005 | US20050260621 Immunoreactive 38-KDA ferric binding protein of ehrlichia canis and uses thereof |
| 11/24/2005 | US20050260616 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 11/24/2005 | US20050260604 Antigens derived from the core protein of the human mammary epithelial mucin |
| 11/24/2005 | US20050260598 Novel clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for the preparation of said protein |
| 11/24/2005 | US20050260582 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same |
| 11/24/2005 | US20050260581 Gonococcal proteins and nucleic acids |
| 11/24/2005 | US20050260580 Erythropoietin and erythropoietin receptor expression in human cancer |
| 11/24/2005 | US20050260579 TGF-beta type receptor cDNAs encoded products |
| 11/24/2005 | US20050260578 Antisense modulation of cellular apoptosis susceptibity gene expression |
| 11/24/2005 | US20050260577 Detection of neurodegenerative disorders |
| 11/24/2005 | US20050260565 contacting in vitro a sample comprising chemokine 88C receptor with a putative ligand, detecting binding of the 88C receptor and the putative ligand; increase in 88C signal transduction activity indicates the ligand is an activator, a decreasein transduction activity indicates the ligand is an inhibitor |
| 11/24/2005 | US20050260560 Administering antigens capable of causing specific immune reaction(s) directed against an infectious agent and/or cells infected with the infectious agent, and decreasing a different specific immune reaction direct towards the infectious agent, infected cells and/or uninfected cells; immunotherapy |
| 11/24/2005 | US20050260559 Antiviral agent against picornavirus infections, the assayselects an agent that disrupts the association between picornavirus protein 2c and the host cell protein DAKAP2for viral replication |
| 11/24/2005 | US20050260277 Method and formula for anti-tumor and anti-matastatic effect |
| 11/24/2005 | US20050260275 Encapsulated peptide copper complexes and compositions and methods related thereto |
| 11/24/2005 | US20050260271 Composition comprising layered host material with intercalated functional-active organic compound |
| 11/24/2005 | US20050260270 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo |
| 11/24/2005 | US20050260259 Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| 11/24/2005 | US20050260258 Use of vitelline protein B as a microencapsulating additive |
| 11/24/2005 | US20050260250 Medicinal products incorporating bound organosulfur groups |
| 11/24/2005 | US20050260237 Delivery Agents for enhancing mucosal absorption of therapeutic agents |
| 11/24/2005 | US20050260234 Anti-neovasculature preparations for cancer |
| 11/24/2005 | US20050260231 treating a mammary gland disorder, including hyperplastic, hypertonic, cystic and/or neoplastic mammary gland tissue by local administration of a botulinum toxin to or to the vicinity of the afflicted breast tissue |
| 11/24/2005 | US20050260230 Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins |
| 11/24/2005 | US20050260227 Novel therapeutic processes for treating cancer with specific antigens |
| 11/24/2005 | US20050260226 Novel therapeutic processes for treating infectious agents by training or adoptive transfer of immune cells, and useful compositions therefor |
| 11/24/2005 | US20050260224 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 11/24/2005 | US20050260223 Salmonella vaccine materials and methods |
| 11/24/2005 | US20050260222 Structure-based receptor MIMICS targeted against bacterial superantigen toxins |
| 11/24/2005 | US20050260218 House dust mite allergen, Der f VII, and uses therefor |
| 11/24/2005 | US20050260216 Polypeptide containing a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 11/24/2005 | US20050260215 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 11/24/2005 | US20050260203 Use of fusion polypeptides capable of binding vascular endothelial cell growth factor (VEGF), VEGF family members, and splice variants with specifically desirable characteristics; therapy for ocular diseases |
| 11/24/2005 | US20050260201 Methods of treating rheumatoid arthritis using anti-TNF receptor fusion proteins |
| 11/24/2005 | US20050260200 Antigenic peptides reacting with anti-ovary antibodies |
| 11/24/2005 | US20050260199 For inhibition of viral entry into cells; purified antibodies |
| 11/24/2005 | US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents |
| 11/24/2005 | US20050260188 Cross-linked gels of chemically activated carboxypolysaccharides and polyalkylene oxides |
| 11/24/2005 | US20050260187 Therapeutic and cosmetic uses of heparanases |
| 11/24/2005 | US20050260186 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant soluble neutral active Hyaluronidase Glycoproteins to enhance stability and serum pharmacokinetics over natural slaughterhouse enzymes; transgenic animals; dosage forms |
| 11/24/2005 | US20050260185 Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase |
| 11/24/2005 | US20050260184 Dual roles of pepper esterase as a biocontrol agent |
| 11/24/2005 | US20050260182 obtained from endophytic Streptomycetes isolated from higher plants; biological activity against plant pathogensPythium ultimum, Phytophthora cinnamomi, Cryptococcus neoformans, Candida albicans; parasitic Plasmodium falciparum; bacterial pathogen, Streptococcus pneumoniae; breast epithelial cancer cell |
| 11/24/2005 | US20050260181 Compositions and methods for tissue repair |
| 11/24/2005 | US20050260180 Materials and methods for treating vascular leakage in the eye |
| 11/24/2005 | US20050260179 Stem and progenitor cell capture for tissue regeneration |
| 11/24/2005 | US20050260174 Systems and methods for treating patients with processed lipoaspirate cells |
| 11/24/2005 | US20050260171 Compositions containing bacteriophages and method of using bacteriophages to treat infections |
| 11/24/2005 | US20050260163 Triplex hairpin ribozyme |
| 11/24/2005 | US20050260161 Method for modulating, regulating and/or stabilizing angiogenesis |
| 11/24/2005 | US20050260155 Compositions and methods for treatment of ulcerative colitis |
| 11/24/2005 | US20050260154 G-CSF analog compositions and methods |
| 11/24/2005 | US20050260140 Mucolytic and anti-elastase compounds and methods of use thereof |
| 11/24/2005 | US20050260133 Strategy for designing patient-specific anti-cancer drugs |
| 11/24/2005 | US20050259281 Method, apparatus and computer program for transforming digital colour images |
| 11/24/2005 | DE102004028302B4 Stimulierung der Synthese und der Aktivität einer Isoform der Lysyloxidase-ähnlichen LOXL zum Stimulieren der Bildung von elastischen Fasern Stimulation of the synthesis and the activity of one isoform of the lysyl oxidase-like LOXL for stimulating the formation of elastic fibers |
| 11/24/2005 | DE102004028300B4 Stimulierung der Aktivität eines Isoform des Lysyloxidase zum Bekämpfen von einigen Pathologien, die durch eine unvollständige, fehlende oder desorganisierte Elastogenese verursacht sind Stimulation of the activity of an isoform of the lysyl oxidase for controlling some pathologies which are caused by an incomplete, missing or disorganized elastogenesis |
| 11/24/2005 | CA2820168A1 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 11/24/2005 | CA2816163A1 Methods and kits to detect hereditary angioedema type iii |